Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes.
Kapadia, M; Lehmann, L; Auletta, J; Beatty, L; Bhatt, N; Blacken, R; Demmel, K; Dodd, T; Desmond, C; Fitch, T; et al.
Transplantation and cellular therapy.
2022;
28:233-241.
Abnormal Maximal and Submaximal Cardiopulmonary Exercise Capacity in Pediatric Stem Cell Transplant Recipients Despite Normal Standard Echocardiographic Parameters: A Pilot Study.
Powell, AW; Urbina, EM; Madueme, P; Rotz, S; Chin, C; Taylor, MD; Mays, WA; Davies, SM; Lane, A; Berger, S; et al.
Transplantation and cellular therapy.
2022;
28:263.e1-263.e5.
Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?.
Jodele, S; Dandoy, CE; Sabulski, A; Koo, J; Lane, A; Myers, KC; Wallace, G; Chima, RS; Teusink-Cross, A; Hirsch, R; et al.
Transplantation and cellular therapy.
2022.
US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity.
Power-Hays, A; Dandoy, CE; Lorts, A; Perentesis, JP; Unaka, N; Ware, RE; McGann, PT.
Pediatric Blood and Cancer.
2022.
Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT.
Mizuno, K; Dandoy, CE; Teusink-Cross, A; Davies, SM; Vinks, AA; Jodele, S.
Blood Advances.
2022;
6:1454-1463.
Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
Gardner, JC; Courter, JD; Dandoy, CE; Davies, SM; Teusink-Cross, A.
Transplantation and cellular therapy.
2022;
28:167.e1-167.e5.
511 Defining Patient-Important Outcomes after Pediatric Hematopoietic Stem Cell Transplant.
Fitch, TJ; Huber, J; Flesch, L; Jaglowski, S; Auletta, JJ; Lehmann, LE; Bhatt, NS; Mueller, M; Rotz, SR; Phelan, R; et al.
Transplantation and cellular therapy.
2022;
28:s399-s400.
179 Weight Loss after Hematopoietic Stem Cell Transplantation for Malignancy.
Fitch, TJ; Myers, KC; Davies, SM; Taggart, CB; Demmel, KM; Dandoy, CE.
Transplantation and cellular therapy.
2022;
28:s148-s149.
Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplant Patients.
Gardner, J; Courter, J; Dandoy, CE; Davies, SM; Teusink-Cross, A.
Transplantation and cellular therapy.
2022;
28.
Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome.
Singh, A; Dandoy, CE; Chen, M; Kim, S; Mulroney, CM; Kharfan-Dabaja, MA; Ganguly, S; Maziarz, RT; Kanakry, CG; Kanakry, JA; et al.
Transplantation and cellular therapy.
2022;
28:48.e1-48.e10.